Royal Philips highlighted its range of magnetic resonance (MR) solutions at the International Society for Magnetic Resonance in Medicine’s (ISMRM) 23rd Annual Meeting & Exhibition, held May 30 to June 5 in Toronto, Canada. Visitors to the Philips booth were able to see the company’s latest MR products, designed in collaboration with clinicians and partners to increase clinical performance, enhance patient experience, and provide economic value. According to Philips, the solutions highlight the company’s commitment to making MR more accessible to patients, while improving diagnostic confidence.
“MR brings the best of cutting-edge technologies and clinical applications in a robust way to address real world clinical challenges and disease states for people around the globe in multiple care settings across the health continuum,” said Vinay Parthan, vice president, research and development of MRI, Philips. “MR is also a nascent imaging modality and has tremendous scope for research and exploration. Philips is excited to collaborate with our research partners as we co-innovate to enhance patient care through intuitive and quantitative MR.”
Philips reports that with its acquisition, reconstruction, and post-processing research tools like the Paradise Pulse Programming environment and Recon 2.0, an MR image reconstruction framework, the company provides research partners access to key algorithms within its MR systems, allowing them to develop their own applications on Philips platforms.
“Our group has had a longstanding collaboration with Philips,” said Chun Yuan, PhD, professor, radiology and bioengineering, University of Washington, and professor and director, Center for Biomedical Imaging Research, Tsinghua University, Beijing, China. “A significant contributor to the success of this collaboration has been the ability to access their MR software source code, which has allowed us to delve deep into the system and create new imaging techniques to help with stroke research. Ultimately, we believe this will help us to create new clinical methods to diagnose and treat patients at risk of having stroke before it happens.”
The Philips booth at ISMRM featured research-only technologies that included the aforementioned Recon 2.0, as well as IntelliSpace Discovery, a multi-modality visualization and analysis solution to facilitate research. The Philips booth also featured the company’s Ingenia MR-RT MR-only simulation, a new approach in therapy that helps clinicians rely on MR as a primary imaging modality for prostate cancer treatment; and the commercially available Ingenia 3.0T CX, which was designed to help clinicians explore new clinical fields with confidence, perform advanced clinical imaging to support referrals, and conduct routine imaging efficiently.
For more information about the range of MR solutions from the company, visit the Royal Philips website.
